Vinge has advised the main owners of Astrego Diagnostics AB in conjunction with the sale of the shares to the Japanese minority owner, Sysmex Corporation.
Astrego has developed a diagnostic tool for determining the presence of bacteria in patient samples and the determination of resistance against different antibiotics (so-called ”Antibiotic Susceptibility Test, AST”).
Vinge’s team consisted of Johan Winnerblad, Eléonore Friberg, Viktoria Owetz Leyva and Gunilla Nyman.
